[1] DESANTIS C, MA J, BRYAN L, et al. Breast cancer statistics, 2013[J].CA Cancer J Clin, 2014, 64(1): 52-62. [2] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424. [3] FAN L, STRASSER-WEIPPL K, LI J J, et al. Breast cancer in China [J]. Lancet Oncol, 2014, 15(7): e279-e289. [4] DESANTIS C E, MA JM, GODING SAUER A, et al. Breast cancer statistics, 2017, racial disparity in mortality by state [J]. CA Cancer J Clin, 2017, 67(6): 439-448. [5] ZUO T T, ZHENG R S, ZENG H M, et al. Female breast cancer incidence and mortality in China, 2013[J]. Thorac Cancer, 2017, 8(3): 214-218. [6] OUZOUNOVA M, VUONG T, ANCEY P B, et al. MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells [J]. BMC Genomics, 2013, 14(1): 139. [7] 陈万青, 郑荣寿. 中国女性乳腺癌发病死亡和生存状况[J]. 中国肿瘤临床, 2015, 42(13): 668-674. [8] REDDY K B. MicroRNA (miRNA) in cancer [J]. Cancer Cell Int, 2015, 15(1): 38. [9] RUPAIMOOLE R, CALIN G A, LOPEZ-BERESTEIN G, et al. MiRNA deregulation in cancer cells and the tumor microenvironment [J]. Cancer Discov, 2016, 6(3): 235-246. [10] TUTAR L, ÖZGÜ R A, TUTAR Y. Involvement of miRNAs and pseudogenes in cancer [J]. Methods Mol Biol, 2018, 1699: 45-66. [11] XU J, WU W B, WANG J, et al. MiR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7[J]. Oncol Rep, 2017, 37(2): 1052-1058. [12] DING D X, ZHANG Y, WEN L, et al. MiR-367 regulates cell proliferation and metastasis by targeting metastasis-associated protein 3(MTA3) in clear-cell renal cell carcinoma [J]. Oncotarget, 2017, 8(38): 63084-63095. [13] MENG X, LU P, FAN Q. miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN [J]. Biochem Biophys Res Commun, 2016, 470(1): 187-191. [14] ZHANG B,HE D D,FANG X J, et al. The microRNA-367 inhibits the invasion and metastasis of gastric cancer by directly repressing Rab23[J]. Genet Test Mol Biomarkers, 2015,19(2): 69-74. [15] JIA Y L, ZHOU J C, LUO X, et al. KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer [J]. Cell Signal, 2018, 42: 165-175. [16] SONG X, XING Y M, WU W, et al. Expression of Krüppel-like factor 4 in breast cancer tissues and its effects on the proliferation of breast cancer MDA-MB-231 cells [J]. Exp Ther Med, 2017, 13(5): 2463-2467. [17] WANG G C, HE Q Y, TONG D K, et al. MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4[J]. J Bone Oncol, 2016, 5(2): 51-56. |